-
Recursion, Exscientia Merge AI Drug Discovery Companies
Bio-IT World | Recursion and Exscientia have entered into a definitive agreement to combine Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities.
Aug 8, 2024
-
Singapore Launches Long-Read Population Sequencing Program with PacBio, Oxford Nanopore
Bio-IT World | Singapore’s National Precision Medicine (NPM) program has launched a long-read sequencing project to gain deeper insights into Asian genetic diversity. The program, Precision Health Research, Singapore (PRECISE) has appointed both Oxford Nanopore Technologies (ONT) and PacBio (PacBio) to deliver sequencing.
Aug 8, 2024
-
Howard Jacob on How AbbVie’s ARCH is Unlocking Major Opportunities
Bio-IT World | At last year’s Bio-IT World Conference & Expo, AbbVie won an Innovative Practices Award for their AbbVie R&D Convergence Hub (ARCH). Their data platform is designed to provide access to knowledge in a faster and more automated way, as well as an easier way to extract insights and connect disparate datasets. Today, three years after the launch of ARCH, AbbVie has made great strides in data convergence with the platform.
Aug 7, 2024
-
GE HealthCare, AWS Collaborate on Gen AI Models
Bio-IT World | GE HealthCare and Amazon Web Services have announced a strategic collaboration to develop purpose-built foundation models and generative artificial intelligence (AI) applications designed to help clinicians improve medical diagnostics and patient care.
Aug 6, 2024
-
BioTeam Acquired by British n2 Group
Bio-IT World | BioTeam announced its acquisition today by British firm n2 Group. BioTeam will be a US-based, independent business within n2 Group. Financial details have not been disclosed.
Aug 2, 2024
-
Youth Diabetes Researchers Invited to Dip Into POND, Make a Hypothesis
Bio-IT World | Soaring rates of youth prediabetes and diabetes over the past few decades have prompted a multidisciplinary team of experts from the Icahn School of Medicine at Mount Sinai (ISMMS) to create a dataset unifying potentially important clues about how to personalize interventions and devise better prevention strategies.
Aug 1, 2024


